Figure 3From: Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness–a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer Changes in Ki67 after short-term treatment of ER-β-positive breast cancer. Back to article page